Boxiong Ni
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Kumatakenin drives renal and hepatic fibrosis via macrophage-to-myofibroblast transition.
Journal: International immunopharmacology
Published: January 20, 2026
Mechanism study of RUNX1/NSUN2 upregulating fatty acid-binding protein 5 through 5-methylcytosine methylation to mediate lipid metabolic reprogramming to promote immunotherapy resistance in non-small cell lung cancer.
Journal: Respiratory research
Published: January 05, 2026
RUNX1 promotes NSCLC progression by ACP5/SMAD3-mediated M2 macrophage polarization.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: May 14, 2025
RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.
Journal: Oncology reports
Published: October 23, 2024
Sevoflurane attenuates proliferative and migratory activity of lung cancer cells via mediating the microRNA-100-3p/sterol O-Acyltransferase 1 axis.
Journal: The Chinese journal of physiology
Published: December 27, 2023
Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer.
Journal: Frontiers in cellular and infection microbiology
Published: November 07, 2022
PIGF and Flt-1 on the surface of macrophages induces the production of TGF-β1 by polarized tumor-associated macrophages to promote lung cancer angiogenesis.
Journal: European journal of pharmacology
Published: June 25, 2021
microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 23, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026